TGFB1 and neoplasm: TGF-β blockade also increases influx of tumor-associated neutrophils with increased cytotoxic/anti-tumor activities whereas, conversely, TGF-β ligand within the tumor microenvironment induces a population of neutrophils with a protumor phenotype [63].